Skip to content
Monday, November 2, 2026
Search
Politics
World
Business
Money
Tech
Science
Health
Sport
Culture
Opinion
Cartoons
pharma
Every story we have filed on this, newest first.
Money
Lilly's Zepbound outlook is now growing faster than Zepbound
Oct 29
· 2 min read
Health
Moderna and Merck shrug at 42% melanoma win, mourn break room kettle
Oct 24
· 1 min read